Gabelli Funds LLC Has $23.07 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Gabelli Funds LLC decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 4.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 69,180 shares of the company’s stock after selling 2,955 shares during the period. Gabelli Funds LLC’s holdings in HCA Healthcare were worth $23,074,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in HCA. Pacer Advisors Inc. raised its position in HCA Healthcare by 8.4% in the fourth quarter. Pacer Advisors Inc. now owns 15,488 shares of the company’s stock worth $4,192,000 after acquiring an additional 1,205 shares during the period. Assenagon Asset Management S.A. raised its position in shares of HCA Healthcare by 2.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 90,551 shares of the company’s stock valued at $24,510,000 after purchasing an additional 2,522 shares during the period. Ritholtz Wealth Management raised its position in shares of HCA Healthcare by 24.9% in the fourth quarter. Ritholtz Wealth Management now owns 8,012 shares of the company’s stock valued at $2,169,000 after purchasing an additional 1,596 shares during the period. Inscription Capital LLC raised its position in shares of HCA Healthcare by 12.9% in the fourth quarter. Inscription Capital LLC now owns 3,445 shares of the company’s stock valued at $932,000 after purchasing an additional 394 shares during the period. Finally, Global Retirement Partners LLC raised its position in shares of HCA Healthcare by 62.3% in the fourth quarter. Global Retirement Partners LLC now owns 10,810 shares of the company’s stock valued at $3,036,000 after purchasing an additional 4,150 shares during the period. Institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the stock. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $329.00 to $378.00 and gave the stock an “outperform” rating in a research note on Wednesday. Barclays boosted their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft increased their price target on shares of HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a research report on Friday, June 28th. Finally, JPMorgan Chase & Co. raised their target price on shares of HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research report on Thursday, May 30th. Four research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $339.72.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP Kathryn A. Torres sold 973 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the sale, the senior vice president now owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 6,311 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the sale, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The disclosure for this sale can be found here. Insiders have sold 12,397 shares of company stock valued at $3,921,929 over the last 90 days. 1.60% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA stock traded up $1.99 during trading hours on Friday, reaching $354.78. The company had a trading volume of 1,215,941 shares, compared to its average volume of 1,679,664. The company has a debt-to-equity ratio of 27.11, a quick ratio of 1.02 and a current ratio of 1.06. The firm has a market cap of $92.92 billion, a PE ratio of 17.69, a price-to-earnings-growth ratio of 1.35 and a beta of 1.68. The business has a fifty day moving average price of $330.12 and a 200-day moving average price of $323.02. HCA Healthcare, Inc. has a one year low of $215.96 and a one year high of $356.30.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm’s revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the firm posted $4.29 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 22.44 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.74%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio is currently 13.16%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.